» Articles » PMID: 16986176

Seeking Informed Consent to Cancer Clinical Trials; Evaluating the Efficacy of Doctor Communication Skills Training

Overview
Journal Psychooncology
Publisher Wiley
Specialties Oncology
Psychology
Date 2006 Sep 21
PMID 16986176
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Clinical trials have come to be regarded as the gold standard for treatment evaluation. However, many doctors and their patients experience difficulties when discussing trial participation, leading to poor accrual to trials and questionable quality of informed consent. We have previously developed a communication skills training program based on a typology for ethical communication about Phase II and III clinical trials within four categories. The training program consisted of a 1 day experiential workshop that included didactic teaching, exemplary video and role play. The aim of this study was to evaluate the effectiveness of the communication skills training workshop.

Method: Oncologists were recruited from three major teaching hospitals conducting oncology outpatient clinics in three Australian capital cities. Ten oncologists and 90 of their adult cancer patients who were eligible for a Phase II or III clinical trial participated. Ninety informed consent consultations were audiotaped before (n = 59) and after (n = 31) training, and fully transcribed. The presence or absence of each domain component was coded and these were summed within categories. A coding manual was produced which enabled standardization of the coding procedure. Patients completed questionnaires before and after the consultation, and doctors completed a short measure of satisfaction after the consultation.

Results: Doctors increased their use of some aspects of shared decision-making behavior (t(87) = -1.945, p = 0.05) and described some aspects of essential ethical/clinical information more commonly. In addition they used less coercive behaviors (z = -1.976, p = 0.048). However, they did not provide more clinical information or structure their consultations in the recommended fashion. Patients in the post-training cohort reported more positive attitudes to clinical trials, but other outcomes were not affected by the intervention.

Conclusions: This short training programme demonstrated limited success in improving the oncologist's communication skills when gaining informed consent. A larger randomized controlled trial of extended training is now underway.

Citing Articles

Cancer clinical trial participation: a qualitative study of Black/African American communities' and patient/survivors' recommendations.

Kaljee L, Antwi S, Dankerlui D, Harris D, Israel B, White-Perkins D JNCI Cancer Spectr. 2024; 9(1).

PMID: 39585656 PMC: 11781321. DOI: 10.1093/jncics/pkae119.


Opportunities to Increase Science of Diversity and Inclusion in Clinical Trials: Equity and a Lack of a Control.

Igwe J, Wangdak Yuthok T, Cruz E, Mueller A, Lan R, Brown-Johnson C J Am Heart Assoc. 2023; 12(24):e030042.

PMID: 38108253 PMC: 10863780. DOI: 10.1161/JAHA.123.030042.


The role of mentoring, supervision, coaching, teaching and instruction on professional identity formation: a systematic scoping review.

Toh R, Koh K, Lua J, Wong R, Quah E, Panda A BMC Med Educ. 2022; 22(1):531.

PMID: 35804340 PMC: 9270794. DOI: 10.1186/s12909-022-03589-z.


Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.

Bizzarri N, Nero C, Sillano F, Ciccarone F, DOria M, Cesario A J Pers Med. 2022; 12(1).

PMID: 35055317 PMC: 8778422. DOI: 10.3390/jpm12010003.


Oncology patients' experiences in experimental medicine cancer trials: a qualitative study.

Sawyer C, Preston L, Taylor S, Davies M, Carter L, Krebs M BMJ Open. 2021; 11(10):e047813.

PMID: 34610932 PMC: 8493921. DOI: 10.1136/bmjopen-2020-047813.